|
1
|
Chan JK, Cheung MK, Husain A, Teng NN,
West D, Whittemore AS, Berek JS and Osann K: Patterns and progress
in ovarian cancer over 14 years. Obstet Gynecol. 108:521–528. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lutz AM, Willmann JK, Drescher CW, Ray P,
Cochran FV, Urban N and Gambhir SS: Early diagnosis of ovarian
carcinoma: is a solution in sight? Radiology. 259:329–345. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goff BA, Mandel LS, Drescher CW, Urban N,
Gough S, Schurman KM, Patras J, Mahony BS and Andersen MR:
Development of an ovarian cancer symptom index: possibilities for
earlier detection. Cancer. 109:221–227. 2007. View Article : Google Scholar
|
|
4
|
Ozols R, Rubin S, Thomas G and Robboy S:
Epithelial ovarian cancer. Hoskins W, Perez CA, Young RC, Barakat
RR, Markman M and Randall ME: Principles and Practice of
Gynecologic Oncology. 4th edition. Lippincott Williams &
Wilkins; Philadelphia: pp. 895–987. 2005
|
|
5
|
Hamilton TC, Young RC, McKoy WM,
Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR
and Ozols RF: Characterization of a human ovarian carcinoma cell
line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer
Res. 43:5379–5389. 1983.PubMed/NCBI
|
|
6
|
Fogh J, Wright WC and Loveless JD: Absence
of HeLa cell contamination in 169 cell lines derived from human
tumors. J Natl Cancer Inst. 58:209–214. 1977.PubMed/NCBI
|
|
7
|
Hamilton TC, Young RC and Ozols RF:
Experimental model systems of ovarian cancer: applications to the
design and evaluation of new treatment approaches. Semin Oncol.
11:285–298. 1984.PubMed/NCBI
|
|
8
|
Bénard J, Da Silva J, De Blois MC, Boyer
P, Duvillard P, Chiric E and Riou G: Characterization of a human
ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude
mice. Cancer Res. 45:4970–4979. 1985.PubMed/NCBI
|
|
9
|
Wilson AP: Characterization of a cell line
derived from the ascites of a patient with papillary serous
cystadenocarcinoma of the ovary. J Natl Cancer Inst. 72:513–521.
1984.PubMed/NCBI
|
|
10
|
Dolo V, Ginestra A, Violini S, Miotti S,
Festuccia C, Miceli D, Migliavacca M, Rinaudo C, Romano FM,
Brisdelli F, et al: Ultrastructural and phenotypic characterization
of CABA I, a new human ovarian cancer cell line. Oncol Res.
9:129–138. 1997.PubMed/NCBI
|
|
11
|
Dolo V, D'Ascenzo S, Violini S, Pompucci
L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S and Pavan A:
Matrix-degrading proteinases are shed in membrane vesicles by
ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis.
17:131–140. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferretti A, D'Ascenzo S, Knijn A, Iorio E,
Dolo V, Pavan A and Podo F: Detection of polyol accumulation in a
new ovarian carcinoma cell line, CABA I: A(1)H NMR study. Br J
Cancer. 86:1180–1187. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Violini S, D'Ascenzo S, Bagnoli M,
Millimaggi D, Miotti S, Canevari S, Pavan A and Dolo V: Induction
of a multifactorial resistance phenotype by high paclitaxel
selective pressure in a human ovarian carcinoma cell line. J Exp
Clin Cancer Res. 23:83–91. 2004.PubMed/NCBI
|
|
14
|
Dolo V, D'Ascenzo S, Giusti I, Millimaggi
D, Taraboletti G and Pavan A: Shedding of membrane vesicles by
tumor and endothelial cells. Ital J Anat Embryol. 110(Suppl 1):
127–133. 2005.PubMed/NCBI
|
|
15
|
Prinetti A, Millimaggi D, D'Ascenzo S,
Clarkson M, Bettiga A, Chigorno V, Sonnino S, Pavan A and Dolo V:
Lack of ceramide generation and altered sphingolipid composition
are associated with drug resistance in human ovarian carcinoma
cells. Biochem J. 395:311–318. 2006. View Article : Google Scholar :
|
|
16
|
Taraboletti G, D'Ascenzo S, Giusti I,
Marchetti D, Borsotti P, Millimaggi D, Giavazzi R, Pavan A and Dolo
V: Bioavailability of VEGF in tumor-shed vesicles depends on
vesicle burst induced by acidic pH. Neoplasia. 8:96–103. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Millimaggi D, Mari M, D' Ascenzo S, Giusti
I, Pavan A and Dolo V: Vasculogenic mimicry of human ovarian cancer
cells: role of CD147. Int J Oncol. 35:1423–1428. 2009.PubMed/NCBI
|
|
18
|
Giusti I, D'Ascenzo S, Millimaggi D,
Taraboletti G, Carta G, Franceschini N, Pavan A and Dolo V:
Cathepsin B mediates the pH-dependent proinvasive activity of
tumor-shed microvesicles. Neoplasia. 10:481–488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Masters JR, Thomson JA, Daly-Burns B, Reid
YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, et
al: Short tandem repeat profiling provides an international
reference standard for human cell lines. Proc Natl Acad Sci USA.
98:8012–8017. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barallon R, Bauer SR, Butler J,
Capes-Davis A, Dirks WG, Elmore E, Furtado M, Kline MC, Kohara A,
Los GV, et al: Recommendation of short tandem repeat profiling for
authenticating human cell lines, stem cells, and tissues. In Vitro
Cell Dev Biol Anim. 46:727–732. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Capes-Davis A, Reid YA, Kline MC, Storts
DR, Strauss E, Dirks WG, Drexler HG, MacLeod RA, Sykes G, Kohara A,
et al: Match criteria for human cell line authentication: where do
we draw the line? Int J Cancer. 132:2510–2519. 2013. View Article : Google Scholar
|
|
22
|
Masters JRW; American Type Culture
Collection Standards Development Organization Workgroup ASN-0002:
Cell line misidentification: the beginning of the end. Nat Rev
Cancer. 10:441–448. 2010. View
Article : Google Scholar
|
|
23
|
Verma R and Babu A: Human Chromosomes:
Principles & Techniques. 2nd edition. McGraw-Hill Inc; New
York, NY: 1995
|
|
24
|
Parson W, Kirchebner R, Mühlmann R, Renner
K, Kofler A, Schmidt S and Kofler R: Cancer cell line
identification by short tandem repeat profiling: power and
limitations. FASEB J. 19:434–436. 2005.PubMed/NCBI
|
|
25
|
Azari S, Ahmadi N, Tehrani MJ and Shokri
F: Profiling and authentication of human cell lines using short
tandem repeat (STR) loci: report from the National Cell Bank of
Iran. Biologicals. 35:195–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Steube KG, Grunicke D and Drexler HG:
Isoenzyme analysis as a rapid method for the examination of the
species identity of cell cultures. In Vitro Cell Dev Biol Anim.
31:115–119. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O'Toole CM, Povey S, Hepburn P and Franks
LM: Identity of some human bladder cancer cell lines. Nature.
301:429–430. 1983. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gown AM and Vogel AM: Monoclonal
antibodies to human intermediate filament proteins. III. Analysis
of tumors. Am J Clin Pathol. 84:413–424. 1985.PubMed/NCBI
|
|
29
|
Quentmeier H, Osborn M, Reinhardt J,
Zaborski M and Drexler HG: Immunocytochemical analysis of cell
lines derived from solid tumors. J Histochem Cytochem.
49:1369–1378. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kaighn ME, Narayan KS, Ohnuki Y, Lechner
JF and Jones LW: Establishment and characterization of a human
prostatic carcinoma cell line (PC-3). Invest Urol. 17:16–23.
1979.PubMed/NCBI
|
|
31
|
Gilbert DA, Reid YA, Gail MH, Pee D, White
C, Hay RJ and O'Brien SJ: Application of DNA fingerprints for
cell-line individualization. Am J Hum Genet. 47:499–514.
1990.PubMed/NCBI
|
|
32
|
Thompson R, Zoppis S and McCord B: An
overview of DNA typing methods for human identification: past,
present, and future. Methods Mol Biol. 830:3–16. 2012. View Article : Google Scholar
|
|
33
|
Silva LM, Montes de Oca H, Diniz CR and
Fortes-Dias CL: Fingerprinting of cell lines by directed
amplification of minisatellite-region DNA (DAMD). Braz J Med Biol
Res. 34:1405–1410. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chambers GK and MacAvoy ES:
Microsatellites: consensus and controversy. Comp Biochem Physiol B
Biochem Mol Biol. 126:455–476. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan R, Ottenbreit M, Hukku B, Mally M,
Chou S and Kaplan J: DNA fingerprinting of human cell lines using
PCR amplification of fragment length polymorphisms. In Vitro Cell
Dev Biol Anim. 32:656–662. 1996. View Article : Google Scholar
|
|
36
|
Korch C, Spillman MA, Jackson TA, Jacobsen
BM, Murphy SK, Lessey BA, Jordan VC and Bradford AP: DNA profiling
analysis of endometrial and ovarian cell lines reveals
misidentification, redundancy and contamination. Gynecol Oncol.
127:241–248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Poetsch M, Petersmann A, Woenckhaus C,
Protzel C, Dittberner T, Lignitz E and Kleist B: Evaluation of
allelic alterations in short tandem repeats in different kinds of
solid tumors - possible pitfalls in forensic casework. Forensic Sci
Int. 145:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vauhkonen H, Hedman M, Vauhkonen M, Kataja
M, Sipponen P and Sajantila A: Evaluation of gastrointestinal
gastrointestinal cancer tissues as a source of genetic information
for forensic investigations by using STRs. Forensic Sci Int.
139:159–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ensenberger MG, Thompson J, Hill B, Homick
K, Kearney V, Mayntz-Press KA, Mazur P, McGuckian A, Myers J, Raley
K, et al: Developmental validation of the PowerPlex 16 HS System:
an improved 16-locus fluorescent STR multiplex. Forensic Sci Int
Genet. 4:257–264. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pejovic T, Heim S, Orndal C, Jin YS,
Mandahl N, Willén H and Mitelman F: Simple numerical chromosome
aberrations in well-differentiated malignant epithelial tumors.
Cancer Genet Cytogenet. 49:95–101. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tibiletti MG, Bernasconi B, Furlan D,
Bressan P, Cerutti R, Facco C, Franchi M, Riva C, Cinquetti R,
Capella C and Taramelli R: Chromosome 6 abnormalities in ovarian
surface epithelial tumors of borderline malignancy suggest a
genetic continuum in the progression model of ovarian neoplasms.
Clin Cancer Res. 7:3404–3409. 2001.PubMed/NCBI
|
